Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose Escalation Studies
Webinars
Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose Escalation Studies
Speakers:
Abie Ekangi, Ph.D.
Vice President. Statistical Consulting
Andreas Schreiner, MD
Vice President, Medical Affairs Neuroscience & Analgesia